Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2021

Sep 3, 2021

32777_dirs_2021-09-03_c77a3950-ec5c-4bd2-9a62-375906b2f7f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2021-09-02

Reporting Person: Kalowski Lee (President and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-02 Ordinary Shares M 10000 $9.82 Acquired 10000 Direct
2021-09-02 Ordinary Shares S 10000 $40.00 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-02 Employee Stock Option (right to buy) $9.82 M 10000 Disposed 2030-01-02 Ordinary Shares (10000) Direct

Footnotes

F1: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan.

F2: This option shall vest one-fourth (1/4) of the total number of shares under option on January 2, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter.